Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer

Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer

Laura Pacini,* Andrew D Jenks,* Simon Vyse,* Christopher P Wilding, Amani Arthur, Paul H Huang Division of Molecular Pathology, The Institute of Cancer Research, London, UK*These authors contributed equally to this workCorrespondence: Paul H HuangDivision of Molecular Pathology, The Institute of Can...

Full description

Bibliographic Details
Main Authors: Pacini L, Jenks AD, Vyse S, Wilding CP, Arthur A, Huang PH
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
egfr
exon 20 insertions
poziotinib
lung cancer
drug resistance
protacs
Online Access:https://www.dovepress.com/tackling-drug-resistance-in-egfr-exon-20-insertion-mutant-lung-cancer-peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/tackling-drug-resistance-in-egfr-exon-20-insertion-mutant-lung-cancer-peer-reviewed-article-PGPM

Similar Items